M&T Bank’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$809K Buy
21,098
+527
+3% +$13.8K ﹤0.01% 996
2026
Q1
$437K Sell
20,571
-1,128
-5% -$22.6K ﹤0.01% 1192
2025
Q4
$354K Buy
21,699
+1,282
+6% +$19.4K ﹤0.01% 1298
2025
Q3
$238K Sell
20,417
-469
-2% -$6.12K ﹤0.01% 1311
2025
Q2
$241K Buy
+20,886
New +$190K ﹤0.01% 1365
2024
Q4
Sell
-9,008
Closed -$203K 1693
2024
Q3
$203K Buy
+9,008
New +$186K ﹤0.01% 1515
2024
Q1
Sell
-4,501
Closed -$252K 1683
2023
Q4
$252K Buy
+4,501
New +$196K ﹤0.01% 1391
2023
Q3
Sell
-3,860
Closed -$215K 1667
2023
Q2
$215K Buy
3,860
+190
+5% +$10.3K ﹤0.01% 1444
2023
Q1
$204K Buy
+3,670
New +$171K ﹤0.01% 1469
2022
Q2
Sell
-2,916
Closed -$222K 1703
2022
Q1
$222K Buy
2,916
+860
+42% +$75.2K ﹤0.01% 1346
2021
Q4
$305K Sell
2,056
-55
-3% -$8.42K ﹤0.01% 1242
2021
Q3
$307K Buy
2,111
+11
+0.5% +$1.89K ﹤0.01% 1221
2021
Q2
$412K Buy
2,100
+287
+16% +$51.9K ﹤0.01% 1115
2021
Q1
$328K Buy
1,813
+104
+6% +$18K ﹤0.01% 1202
2020
Q4
$242K Buy
+1,709
New +$248K ﹤0.01% 1423

Other funds holding TXG

M&T Bank's TXG Position: Q2 2026 in Review

M&T Bank increased its 10x Genomics (TXG) stake by 2.6% in Q2 2026, buying an estimated $13.8K and bringing the position to 21,098 shares worth $809K. The position accounts for ﹤0.01% of the portfolio, ranked #996.

M&T Bank first reported a position in TXG in Q4 2020 and has held it in 15 quarters since. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • M&T Bank held 21,098 shares of 10x Genomics worth $809K as of Q2 2026.
  • M&T Bank bought 527 10x Genomics shares in Q2 2026, an estimated $13.8K.
  • 10x Genomics made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #996 holding.
  • M&T Bank first reported a position in 10x Genomics in Q4 2020 and has held it in 15 quarters since.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.